Galenica

FY 2019 sales trump expectations, EBIT guidance upgraded

22/01/20 -"Galenica reported FY 19 sales of CHF 3.3bn, +4.3%, with broad-based growth across segments – services +2.9% to CHF 2.4bn and ‘health & beauty’ segment, +6.3%, to CHF 1.6bn. Management now ..."

PDF page sample
Pages
47
Language
English
Published on
22/01/20
Download
You may also be interested by these reports :
02/01/26
We cut our TP to EUR 96.00 (prev.: EUR 118.00) – Add
19/12/25
Soft 3Q results but full year guidance on FY25/26E confirmed
18/12/25
Currys delivered a stronger-than-expected H1 FY25/26, with broad-based earnings growth and strong free cash flow. UK&I gained market share despite ...
18/12/25
Avolta has secured the duty-free concession at Shanghai Pudong Airport T1 and S1, becoming the first international operator to enter mainland China’s ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO